中西医治疗冠状动脉支架术后再狭窄的研究进展  

Research Progress in Treatment of Intracoronary Stent Restenosis by Integrated Traditional Chinese and Western Medicine

作　　者：朱明建 杨洁[2] 张文斌 庄欣[2] ZHU Mingjian;YANG Jie;ZHANG Wenbin;ZHUANG Xin(The First Clinical Medical College,Shandong University of Chinese Medicine,Jinan 250355,China;Department of Heart Diseases,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China)

机构地区：[1]山东中医药大学第一临床医学院,济南250355 [2]山东中医药大学附属医院心病科,济南250011

出　　处：《医学综述》2020年第24期4916-4920,共5页Medical Recapitulate

基　　金：国家自然科学基金(81804061);山东省中医药科技发展计划项目(2019-0099)。

摘　　要：近年来,冠状动脉支架术后再狭窄(ISR)的发病率逐渐升高,成为西医介入治疗的难题。西医认为,ISR的发病机制十分复杂,病理生理过程复杂多变,虽然随着药物洗脱支架的临床应用,其发生率降低,但药物洗脱支架术后不可避免发生支架内ISR,故使西医治疗ISR存在一定的局限性。而中医通过辨证论治,分型治疗可以弥补西医治疗的不足,起到较好的治疗效果,可降低ISR患者病死率。未来对于ISR的治疗应中西医结合治疗为主,要充分发挥中西医结合优势,达到标本兼治的目的。In recent years,the incidence of intracoronary stent restenosis(ISR)has gradually increased,which has become a difficult problem for interventional therapy in western medicine.Western medicine believes that the pathogenesis of ISR is quite complex,and the pathophysiological process is complex and changeable.Although the morbidity of ISR decreases with the application of drug-eluting stents in clinic,in-stent ISR is still inevitable after drug-eluting stents.Therefore,it still has some limitations in the treatment of ISR by western medicine.However,traditional Chinese medicine(TCM)can make up for the deficiency through syndrome and type differentiated treatment,and decrease the mortality of ISR.In the future,to address both symptoms and root causes,the treatment of ISR should be based on the combination of TCM and western medicine.

关 键 词：冠状动脉支架术后再狭窄 中西医 分型治疗 

分 类 号：R541.4[医药卫生—心血管疾病]